These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33471702)

  • 1. The Quantitative Relationship Between Autonomous Cortisol Secretion, Dysglycemia and the Metabolic Syndrome.
    Bleier J; Shlomai G; Fishman B; Dotan Z; Rosenzweig B; Tirosh A
    Endocr Pract; 2020 Sep; 26(9):974-982. PubMed ID: 33471702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between adrenal adenoma size, autonomous cortisol secretion and metabolic derangements.
    Bleier J; Pickovsky J; Apter S; Fishman B; Dotan Z; Tirosh A; Shlomai G
    Clin Endocrinol (Oxf); 2022 Mar; 96(3):311-318. PubMed ID: 34877671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the 1mg-dexamethasone suppression test a precise marker of glucocorticoid excess and cardiometabolic risk in patients with adrenal incidentalomas?
    Araujo-Castro M; Hanzu FA; Pascual-Corrales E; García Cano AM; Marchan M; Escobar-Morreale HF; Valderrabano P; Casals G
    Endocrine; 2023 Oct; 82(1):161-170. PubMed ID: 37351760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of the dexamethasone suppression test for the prediction of autonomous cortisol secretion-related comorbidities in adrenal incidentalomas.
    Araujo-Castro M; Parra Ramírez P; Robles Lázaro C; García Centeno R; Gracia Gimeno P; Fernández-Ladreda MT; Sampedro Núñez MA; Marazuela M; Escobar-Morreale HF; Valderrabano P
    Hormones (Athens); 2021 Dec; 20(4):735-744. PubMed ID: 34273083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonfunctioning adrenal incidentalomas with cortisol post-dexamethasone suppression test >0.9 µg/dL have a higher prevalence of cardiovascular disease than those with values ≤0.9 µg/dL.
    Araujo-Castro M; Parra Ramírez P; Martín Rojas-Marcos P; García Centeno R; Gracia Gimeno P; Tomé Fernández-Ladreda M; Sampedro Núñez MA; Higueruela C; Robles Lázaro C
    Endocrine; 2023 Feb; 79(2):384-391. PubMed ID: 36261701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: a 13-year retrospective study from one center.
    Patrova J; Kjellman M; Wahrenberg H; Falhammar H
    Endocrine; 2017 Nov; 58(2):267-275. PubMed ID: 28887710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiometabolic profile of non-functioning and autonomous cortisol-secreting adrenal incidentalomas. Is the cardiometabolic risk similar or are there differences?
    Araujo-Castro M; Robles Lázaro C; Parra Ramírez P; Cuesta Hernández M; Sampedro Núñez MA; Marazuela M
    Endocrine; 2019 Dec; 66(3):650-659. PubMed ID: 31473918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive model for autonomous cortisol secretion development in non-functioning adrenal incidentalomas.
    Araujo-Castro M; García Cano AM; Escobar-Morreale HF; Valderrabano P
    Hormones (Athens); 2023 Mar; 22(1):51-59. PubMed ID: 36279032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Steroid Profile of Adrenal Incidentalomas: Subtyping Subjects With High Cardiovascular Risk.
    Di Dalmazi G; Fanelli F; Zavatta G; Ricci Bitti S; Mezzullo M; Repaci A; Pelusi C; Gambineri A; Altieri P; Mosconi C; Balacchi C; Golfieri R; Cosentino ER; Borghi C; Vicennati V; Pasquali R; Pagotto U
    J Clin Endocrinol Metab; 2019 Nov; 104(11):5519-5528. PubMed ID: 31381072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saliva versus serum cortisol to identify subclinical hypercortisolism in adrenal incidentalomas: simplicity versus accuracy.
    Vieira-Correa M; Giorgi RB; Oliveira KC; Hayashi LF; Costa-Barbosa FA; Kater CE
    J Endocrinol Invest; 2019 Dec; 42(12):1435-1442. PubMed ID: 31456173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous assay of cortisol and dexamethasone improved diagnostic accuracy of the dexamethasone suppression test.
    Ueland GÅ; Methlie P; Kellmann R; Bjørgaas M; Åsvold BO; Thorstensen K; Kelp O; Thordarson HB; Mellgren G; Løvås K; Husebye ES
    Eur J Endocrinol; 2017 Jun; 176(6):705-713. PubMed ID: 28298353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy of the different hormonal tests used for the diagnosis of autonomous cortisol secretion.
    Araujo-Castro M; García Cano A; Jiménez Mendiguchía L; Escobar-Morreale HF; Valderrábano P
    Sci Rep; 2021 Oct; 11(1):20539. PubMed ID: 34654835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired Cognitive Function in Patients With Autonomous Cortisol Secretion in Adrenal Incidentalomas.
    Liu MS; Tian ZY; Zhang Z; Yang F; Lou Y; Wang YJ; Zeng YJ; Zhang ZW; Zhu DL; Li P
    J Clin Endocrinol Metab; 2023 Feb; 108(3):633-641. PubMed ID: 36263685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and incidence of type 2 diabetes mellitus in patients with adrenal incidentalomas: a study of 709 cases.
    Brox-Torrecilla N; García Cano AM; Valderrábano P; Quintero Tobar A; Escobar-Morreale HF; Araujo-Castro M
    Endocrine; 2023 Sep; 81(3):484-491. PubMed ID: 37212980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autonomous cortisol secretion in adrenal incidentalomas and increased visceral fat accumulation during follow-up.
    Yener S; Baris M; Peker A; Demir O; Ozgen B; Secil M
    Clin Endocrinol (Oxf); 2017 Nov; 87(5):425-432. PubMed ID: 28656620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maximum adenoma diameter, regardless of uni- or bilaterality, is a risk factor for autonomous cortisol secretion in adrenal incidentalomas.
    Araujo-Castro M; Robles Lázaro C; Parra Ramírez P; García Centeno R; Gracia Gimeno P; Fernández-Ladreda MT; Sampedro Núñez MA; Marazuela M; Escobar-Morreale HF; Valderrabano P
    J Endocrinol Invest; 2021 Nov; 44(11):2349-2357. PubMed ID: 33683661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenalectomy improves blood pressure control in nonfunctioning adrenal incidentalomas and glycemic and lipid control in patients with autonomous cortisol secretion.
    Araujo-Castro M; Mínguez Ojeda C; Sánchez Ramírez MN; Gómez Dos Santos V; Pascual-Corrrales E; Fernández-Argüeso M
    Endocrine; 2022 Oct; 78(1):142-150. PubMed ID: 35751779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum cortisol level after low dose dexamethasone suppression test may be predictive for diabetes mellitus and hypertension presence in obese patients: A retrospective study.
    Hepsen S; Sencar E; Sakiz D; Akhanli P; Ucan B; Unsal I; Ozbek M; Cakal E
    Diabetes Res Clin Pract; 2020 Mar; 161():108081. PubMed ID: 32068098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenal incidentaloma: Do patients with apparently nonfunctioning mass or autonomous cortisol secretion have similar or different clinical and metabolic features?
    Rebelo JFD; Costa JM; Junqueira FD; Fonseca AO; de Almeida ABABS; Moraes AB; Vieira Neto L
    Clin Endocrinol (Oxf); 2023 May; 98(5):662-669. PubMed ID: 36514987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular features of possible autonomous cortisol secretion in patients with adrenal incidentalomas.
    Sbardella E; Minnetti M; D'Aluisio D; Rizza L; Di Giorgio MR; Vinci F; Pofi R; Giannetta E; Venneri MA; Vestri A; Morelli S; Lenzi A; Isidori AM
    Eur J Endocrinol; 2018 May; 178(5):501-511. PubMed ID: 29510982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.